DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of Treatment
PHASE2
This study evaluates the therapeutic effects of autologous dendritic cells ...
Status
Unknown
Location
Chinese Academy of Medical Sciences Tumor Hospital
A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer
PHASE1
The main purpose of this study is to evaluate the safety, tolerability, pha...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician.
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
PHASE3
The study will compare the efficacy and safety of pembrolizumab plus trastu...
Status
Completed
Location
UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0045)